Mipasetamab Antibody
Mipasetamab is an IgG1κ monoclonal antibody targeting the AXL receptor tyrosine kinase. It serves as the antibody component of the ADC ADCT-601 (mipasetamab uzoptirine), which demonstrates anti-tumor activity in preclinical research, supporting investigations in oncology and ADC development.
Product Specifications
Product Name Alternative
ADC Antibody, ADCAntibody
Target
TAM Receptor
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
5.56 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog